Multiple Miscarriages, Normal Bloodwork. Here's the Genetic Reason.

MTHFR encodes an enzyme that drives the methylation cycle, a process your cells use billions of times per day. During pregnancy, methylation is not a minor detail. It is how your embryo builds its neural tube, how it sets up its basic architecture, and how it regulates gene expression. Without proper methylation, embryos cannot develop normally.

The MTHFR C677T variant, carried by roughly 40% of people with European ancestry, reduces enzyme efficiency by 40-70%. If you are homozygous for C677T (you carry two copies), your methylation capacity is substantially compromised. That means your body struggles to convert dietary folate into the methylfolate form your embryo actually needs. Your homocysteine climbs. Your embryo does not receive the biochemical support it requires. Embryos from people with MTHFR variants are significantly more likely to miscarry, especially in the first trimester when methylation demand is highest.

You may have been told to take folic acid. If you have an MTHFR variant, folic acid is almost useless to you. Your broken enzyme cannot convert it into its active form. You end up with circulating folate that your cells cannot use, while your embryo starves for the methylated form it desperately needs.

FSHR is the FSH receptor. FSH is the hormone your pituitary sends to tell your ovaries to grow follicles and produce eggs. But your ovaries cannot hear that signal unless they have functioning FSH receptors. The FSHR gene encodes that receptor. The N680S variant determines how sensitive your ovaries are to FSH stimulation.

If you carry the S/S variant of FSHR, present in roughly 10-15% of women, your ovarian response to FSH is poor. When you take fertility medications during IVF, your ovaries do not respond as robustly as they should. You produce fewer eggs. The eggs you do produce tend to be lower quality. Women with the FSHR S/S variant have significantly higher miscarriage rates and lower pregnancy rates with standard IVF protocols. This is not because your ovaries are failing. It is because your ovaries need more FSH signaling to produce viable eggs.

You may have been told you have low ovarian reserve or poor egg quality for your age. You may have cycled through multiple failed IVF attempts. None of it made sense because your basic hormone levels and ultrasounds looked reasonable. But if you carry the S/S FSHR variant, reasonable FSH doses are not enough.

ESR1 encodes the estrogen receptor, the protein on uterine cells that allows them to respond to estrogen. Estrogen is how your uterus prepares itself to receive an embryo. If your estrogen receptors are not functioning optimally, your endometrium does not develop the structure and biochemistry necessary for implantation. The embryo arrives at the window of implantation and finds an inhospitable environment.

The PvuII and XbaI variants in ESR1 affect how sensitive your endometrium is to estrogen signaling. Roughly 40% of women carry these variants. If you carry the XX genotype at the PvuII locus, your endometrial estrogen receptor sensitivity is reduced, and your miscarriage risk increases significantly, particularly in the luteal phase when estrogen levels drop. You may have a structurally normal uterus. Your embryo may be chromosomally normal. But biochemically, your endometrium is not responsive enough to support implantation and early pregnancy maintenance.

You may have tried multiple embryo transfers that failed for no clear reason. Your uterine lining looks thick enough on ultrasound. But your uterus is not receiving the estrogen signal it needs to maintain pregnancy. This is not a problem your doctor can fix with an ultrasound or a blood test.

CFTR encodes a chloride channel that is essential for proper development of the reproductive tract in men. While everyone knows cystic fibrosis is a lung disease, few people realize that CFTR variants profoundly affect male fertility. Men who carry CFTR mutations often have congenital bilateral absence of the vas deferens (CBAVD), meaning the tubes that transport sperm from the testes are not present or are blocked.

CFTR carrier variants are present in roughly 1 in 25 people of European ancestry. If your male partner carries even one CFTR mutation, he may produce sperm normally, but those sperm cannot exit the testes because the ductwork is malformed or absent. The result is azoospermia (no sperm in ejaculate) or severe oligospermia (very few sperm). If your partner is a CFTR carrier, standard semen analysis will show low or absent sperm, but the actual problem is anatomical, not testicular function. His sperm-producing cells are working fine. They have nowhere to go.

You may have been told your male partner has idiopathic infertility or that his sperm count is inexplicably low. If CFTR carrier status was never tested, the actual cause has been missed. This is especially critical for couples planning IVF or considering assisted reproductive technologies, because the solution changes completely.

DAZL and the related AZF genes (azoospermia factors) on the Y chromosome are essential for spermatogenesis, the process by which immature germ cells develop into mature sperm. These genes encode proteins that regulate translation and meiosis. Without them, sperm cannot be produced. DAZL deletions (AZFa, AZFb, or AZFc) are among the most common genetic causes of male infertility.

Deletions in DAZL occur in roughly 1 in 2,000-3,000 men with infertility. If your male partner carries a DAZL deletion, he will have either complete azoospermia (zero sperm) or severe oligospermia (extremely low sperm count). These deletions directly prevent sperm cell development at a fundamental level, and they are not reversible through lifestyle, supplements, or medication. This is not hormonal. This is not testicular inflammation. This is a genetic deletion that removes the instructions for making sperm.

If your partner has azoospermia that appears idiopathic (no clear cause), he has likely not been tested for DAZL and AZF deletions. A semen analysis alone cannot tell you whether the absence of sperm is due to a blockage (like CFTR mutations) or a genetic deletion (like DAZL). The distinction is critical because it determines your reproductive options.

The AR gene encodes the androgen receptor, the protein that allows testosterone to exert its effects throughout your body, including in the testes where it is absolutely required for spermatogenesis. The AR gene contains a variable number of CAG repeats in its coding sequence. The number of repeats you carry directly determines how sensitive your cells are to testosterone signaling.

If you carry a longer CAG repeat length (typically 24 or more repeats), your androgen receptor is less sensitive to testosterone. This is common; it occurs across all ancestry groups. Men with longer CAG repeats have reduced androgen receptor sensitivity, which impairs spermatogenesis and can result in low sperm count or poor sperm motility even when testosterone levels are normal. Your partner’s testosterone may be in the normal range. His testicles may appear normal. But his cells are simply not responding to testosterone the way they should, so sperm production suffers.

You may have had your partner’s testosterone checked. It came back normal. You were told his infertility is idiopathic or unexplained. But if nobody tested his AR CAG repeat length, the actual biological reason has been missed. This is a cellular sensitivity problem, not a hormone production problem.